查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2028年临床试验成像市场预测 - COVID-19的影响和全球分析，按模式、服务（操作成像服务、成像软件、阅读分析服务、试验设计和咨询服务及其他）和终端用户分类
市场调查报告书
商品编码
1296741

2028年临床试验成像市场预测 - COVID-19的影响和全球分析，按模式、服务（操作成像服务、成像软件、阅读分析服务、试验设计和咨询服务及其他）和终端用户分类

Clinical Trial Imaging Market Forecast to 2028 - Global Analysis By Modality, Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User
出版日期: | 出版商: The Insight Partners | 英文 186 Pages | 订单完成后即时交付

价格

预计到2028年，临床试验成像市场规模将从2022年的16.1亿美元达到24.8亿美元；估计从2023年到2028年将录得7.6%的复合增长率。

提供医学影像服务的CRO数量激增促进了市场增长

临床研究组织（CRO）通过使用高质量的设施和深入的主题专业知识提供的服务，协助临床试验的成功实施。由于CRO的高效和具有成本效益的运作使试验申办者受益，他们已成为临床试验行业的骨干力量。例如，平均而言，CRO在进行和完成临床试验方面比内部活动的时间要少30%。

随着CRO数量的增加，导致竞争激烈，其中一些企业提供专门的成像服务，因此出现了成像CRO（iCROs）。Keosys医学影像公司和Medica Group PLC就是iCROs的例子。自2010年以来，临床试验的总数翻了一番，而在这些试验中使用的成像方式增加了近500%。根据KEOSYS MEDICAL IMAGING公司的一份报告，iCROs将其预算的7.5-10%用于成像，这有助于他们优化工作流程，管理从图像采集到解释的每一步。这些CRO在成像的场地资格、标准化图像的获取、读取设计和标准的确定等方面提供关键的知识见解，从而促进了整个临床试验成像市场的增长。

市场机会

硅片成像临床试验将在未来几年提供市场机会

根据SPIE 2023年的一份报告，临床试验是昂贵而漫长的，这导致了监管评估的延迟，并极大地影响了患者对新型和高质量药品的获取。在评估成像技术的安全性和有效性时采用了硅片成像技术，与临床试验相比负担较小，因为它们提供了最小的误差。临床试验中的仿真成像有助于对整个成像系统/其组成部分（来源、对象、任务、观察者组成部分等）进行计算机模拟，这有助于研究、开发、优化、技术评估和监管评估。

模拟成像试验对评估新的医学成像系统至关重要。2019年3月，监管评估虚拟成像临床试验（VICTRE）采用计算机模拟成像，对2986名仿真患者进行了数字乳腺摄影和数字乳房断层合成术的比较。纳入仿真试验改善了病变检测性能，对所有乳房大小和病变类型来说都有利于断层合成。VICTRE的研究结果显示，仿真成像试验和计算机模拟成像工具可能成为成像设备监管评估中可行的证据来源，反过来又为临床试验成像市场的增长提供了有利可图的机会。

2022年，中国占据了亚太地区临床试验成像市场的最大份额，预计在预测期内的复合年增长率为8.6%。中国市场的增长主要归功于成熟的制药市场、制药和生物制药公司不断增加的研发支出、由于成本较低而不断增加的临床试验数量，以及有利的监管政策。中国拥有世界第二大医药市场。中国人口过多，加上各种传染病和非传染病的流行，是有利于中国制药公司发展的关键因素。

临床试验成像市场的主要参与者通过各种策略确保增长。2022年1月，为临床试验提供解决方案的技术公司Clario和放射性药物生产和正电子发射断层扫描公司XingImaging扩大了合作关系，在中国提供PET成像临床试验，以测试新型治疗方法。

国家卫生研究院的临床研究网络、美国疾病控制和预防中心（CDC）、南澳大利亚州卫生和医学研究所、探索性肿瘤学研究和临床试验中心以及治疗用品管理局（TGA）是在编写临床试验成像市场报告时参考的几个主要的第一和第二来源。

目录

第一章：简介

  • 本研究的范围
  • Insight Partners的研究报告指导
  • 市场细分
    • 全球临床试验成像市场 - 按模式划分
    • 全球临床试验成像市场 - 按产品分类
    • 全球临床试验成像市场 - 按终端用户划分
    • 全球临床试验成像市场 - 按地理区域划分

第二章：临床试验成像市场 - 主要结论

第三章：研究方法

  • 覆盖面
  • 二级研究
  • 初级研究

第四章：临床试验成像市场 - 市场格局

  • 市场概况
  • PEST分析
    • 北美洲PEST分析
    • 欧洲PEST分析
    • 亚太地区PEST分析
    • 中东和非洲PEST分析
    • 南美和中美洲PEST分析
  • 专家意见

第五章：临床试验成像市场 - 主要市场动态

  • 市场驱动力
    • 制药和生物技术行业的临床试验活动加速发展
    • 提供医学影像服务的CRO数量激增
  • 市场限制因素
    • 高投资和标准化的基础设施要求
  • 市场机会
    • 线性成像临床试验
  • 未来趋势
    • 人工智能驱动的临床试验
  • 影响分析

第六章：临床试验成像市场 - 全球分析

  • 全球临床试验成像市场收入预测和分析
  • 按地理区域分類的全球临床试验成像市场 - 预测与分析
  • 主要参与者的市场定位

第七章 ：2028年临床试验成像市场收入和预测 - 按模式划分

  • 概述
  • 按模式划分，临床试验成像市场收入份额（2022年和2028年）
  • 断层扫描
  • 超声波
  • 正电子发射断层扫描
  • X-射线
  • 超声心动图
  • 磁共振成像
  • 其他

第八章：2028年临床试验成像市场收入和预测 - 提供服务

  • 概述
  • 临床试验成像市场收入份额，按服务项目划分（2022年和2028年）
  • 试验设计咨询服务
    • 概述
  • 阅读分析服务
    • 概述
  • 操作成像服务
    • 医学影像服务简介
  • 成像软件
    • 纵览
  • 其他
    • 概述

第九章：2028年临床试验成像市场收入和预测 - 按终端用户划分

  • 概述
  • 临床试验成像市场收入份额，按终端用户划分（2022年和2028年）
  • 制药和生物制药公司
  • 合同研究组织
  • 学术和研究机构
  • 其他

第十章：临床试验成像市场 - 2028年的收入和预测 - 地域分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳大利亚
    • 亚太其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美和中美洲其他地区
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 中东和非洲其他地区

第十一章：COVID-19大流行对临床试验成像市场的影响

  • 北美洲：对COVID-19大流行的评估
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
  • 中东和非洲

第十二章 ：临床试验成像市场 - 行业格局

  • 概述
  • 临床试验成像市场的增长策略
  • 无机增长战略
    • 概述
  • 有机增长策略
    • 综述

第十三章 ：公司简介

  • eResearch Technology Inc
  • Calyx Inc
  • ICON PLC
  • VIDA Diagnostics Inc
  • WCG Clinical Inc
  • BioTelemetry Inc
  • Medical Metrics Inc
  • Medpace Holdings Inc
  • Radiant Sage LLC
  • IXICO plc

第十四章：附录

  • 关于洞察力合作伙伴
  • 术语表
Product Code: TIPHE100001201

The clinical trial imaging market size is expected to reach US$ 2.48 billion by 2028 from US$ 1.61 billion in 2022; it is estimated to record a CAGR of 7.6% from 2023 to 2028.

Spur in Number of CROs Offering Medical Imaging Services Bolsters Market Growth

Clinical research organizations (CROs) assist in the successful implementation of clinical trials through the services offered using high-quality facilities and deep subject matter expertise. CROs have become the backbone of the clinical trial industry due to their efficient and cost-effective operations that benefit trial sponsors. For example, on an average, CROs take 30% lesser time than in-house activity to conduct and complete clinical trials.

With the rising number of CROs, leading to high competition, some of these businesses offer specialized imaging services, thus emerging as imaging CROs (iCROs). Keosys Medical Imaging and Medica Group PLC are the examples of iCROs. The total number of clinical trials has doubled since 2010, and the use of imaging modalities in these trials has increased by almost 500%. Per a report by KEOSYS MEDICAL IMAGING company, iCROs allocate 7.5-10% of their budgets for imaging, which helps them optimize their workflow to manage every step of the process, from image acquisition to interpretation. These CROs offer key knowledge insights in areas such as site qualification for imaging, acquisition of standardized images, and determination of read designs and criteria, thereby contributing to the growth of the overall clinical trial imaging market.

Market Opportunity

In-Silico Imaging Clinical Trials to Provide Market Opportunities in Coming Years

According to a 2023 report by the SPIE, clinical trials are expensive and lengthy, which causes delays in regulatory evaluation and significantly affects patients' access to novel and high-quality pharmaceutical products. In-silico imaging is employed in the evaluation of safety and effectiveness of imaging technologies with less burden than clinical trials as they provide minimal errors. In-silico imaging in clinical trials aid in the computer simulation of an entire imaging system/its components (source, object, task, observer components, etc.), which assists in research, development, optimization, technology assessment, and regulatory evaluation.

In-silico imaging trials are vital in evaluating new medical imaging systems. In March 2019, the Virtual Imaging Clinical Trial for Regulatory Evaluation (VICTRE) was conducted using computer-simulated imaging of 2,986 in-silico patients for comparing digital mammography and digital breast tomosynthesis. Incorporating in-silico trials improved lesion detection performance, favoring tomosynthesis for all breast sizes and lesion types. Findings of VICTRE reveal that in-silico imaging trials and computer simulation imaging tools are likely to be viable sources of evidence in the regulatory evaluation of imaging devices, in turn, providing lucrative opportunities for the growth of the clinical trial imaging market.

China held the largest share of the clinical trial imaging market in Asia Pacific in 2022, and it is expected to register a CAGR of 8.6% during the forecast period. The growth of the market in China is primarily attributed to the established pharmaceutical market, increasing R&D expenditures by the pharmaceutical and biopharmaceutical companies, rising number of clinical trials due to lower cost, and favorable regulatory policies. China has the world's second largest pharmaceutical market. The excessive population in China, coupled with the prevalence of various communicable and non-communicable diseases, are the key factors favoring the growth of the pharmaceutical companies in China.

Key players in the clinical trial imaging market secure growth through various strategies. In January 2022, Clario, a technology company that delivers solutions for clinical trials, and XingImaging, a radiopharmaceutical production and positron emission tomography company, expanded their partnership to deliver PET imaging clinical trials for testing novel therapeutics in China.

The National Institute for Health Research's Clinical Research Network, the Centers for Disease Control and Prevention (CDC), South Australian Health and Medical Research Institute, Exploratory Oncology Research & Clinical Trial Center, and Therapeutic Goods Administration (TGA) are a few key primary and secondary sources referred to while preparing the report on the clinical trial imaging market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the clinical trial imaging market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global clinical trial imaging market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Clinical Trial Imaging Market - by Modality
    • 1.3.2 Global Clinical Trial Imaging Market - by Offering
    • 1.3.3 Global Clinical Trial Imaging Market - by End User
    • 1.3.4 Global Clinical Trial Imaging Market - by Geography

2. Clinical Trial Imaging Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Clinical Trial Imaging Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East and Africa PEST Analysis
    • 4.2.5 South and Central America PEST Analysis
  • 4.3 Expert Opinion

5. Clinical Trial Imaging Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Accelerated Clinical Trial Activities in Pharmaceutical and Biotechnology Industry
    • 5.1.2 Spur in Number of CROs Offering Medical Imaging Services
  • 5.2 Market Restraints
    • 5.2.1 High Investment and Standardized Infrastructure Requirements
  • 5.3 Market Opportunities
    • 5.3.1 In-Silico Imaging Clinical Trials
  • 5.4 Future Trends
    • 5.4.1 AI-Driven Clinical Trials
  • 5.5 Impact Analysis

6. Clinical Trial Imaging Market - Global Analysis

  • 6.1 Global Clinical Trial Imaging Market Revenue Forecast and Analysis
  • 6.2 Global Clinical Trial Imaging Market, by Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Clinical Trial Imaging Market Revenue and Forecast To 2028 - by Modality

  • 7.1 Overview
  • 7.2 Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
  • 7.3 Tomography
    • 7.3.1 Overview
    • 7.3.2 Tomography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Ultrasound
    • 7.4.1 Overview
    • 7.4.2 Ultrasound: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Positron Emission Tomography
    • 7.5.1 Overview
    • 7.5.2 PET: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 X-Ray
    • 7.6.1 Overview
    • 7.6.2 X-Ray: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Echocardiography
    • 7.7.1 Overview
    • 7.7.2 Echocardiography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.8 Magnetic Resonance Imaging
    • 7.8.1 Overview
    • 7.8.2 Magnetic Resonance Imaging: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.9 Others
    • 7.9.1 Overview
    • 7.9.2 Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

8. Clinical Trial Imaging Market Revenue and Forecast To 2028 - Offering

  • 8.1 Overview
  • 8.2 Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
  • 8.3 Trial Design Consulting Services
    • 8.3.1 Overview
    • 8.3.2 Trial Design Consulting Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Read Analysis Services
    • 8.4.1 Overview
    • 8.4.2 Read Analysis Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Operational Imaging Services
    • 8.5.1 Overview
    • 8.5.2 Operational Imaging Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Imaging Software
    • 8.6.1 Overview
    • 8.6.2 Imaging Software: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

9. Clinical Trial Imaging Market Revenue and Forecasts To 2028- by End User

  • 9.1 Overview
  • 9.2 Clinical Trial Imaging Market Revenue Share, by End User (2022 and 2028)
  • 9.3 Pharmaceutical and Biopharmaceutical Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biopharmaceutical Companies: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Contract Research Organizations
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organizations: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

10. Clinical Trial Imaging Market - Revenue and Forecast to 2028 - Geographic Analysis

  • 10.1 North America: Clinical Trial Imaging Market
    • 10.1.1 Overview
    • 10.1.2 North America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.1.3 North America: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    • 10.1.4 North America: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    • 10.1.5 North America: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
    • 10.1.6 North America: Clinical Trial Imaging Market, by Country, 2022& 2028 (%)
      • 10.1.6.1 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.1 Overview
        • 10.1.6.1.2 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.3 US: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.6.1.4 US: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.1.6.1.5 US: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.1.6.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.1 Overview
        • 10.1.6.2.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.3 Canada: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.6.2.4 Canada: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.1.6.2.5 Canada: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.1.6.3 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.1 Overview
        • 10.1.6.3.2 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.3 Mexico: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.6.3.4 Mexico: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.1.6.3.5 Mexico: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  • 10.2 Europe: Clinical Trial Imaging Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.3 Europe: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    • 10.2.4 Europe: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    • 10.2.5 Europe: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
    • 10.2.6 Europe: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
      • 10.2.6.1 Germany: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 Germany: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.3 Germany: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.1.4 Germany: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.1.5 Germany: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.2 UK: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 UK: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.3 UK: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.2.4 UK: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.2.5 UK: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.3 France: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 France: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.3 France: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.3.4 France: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.3.5 France: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.4 Italy: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.3 Italy: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.4.4 Italy: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.4.5 Italy: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.5 Spain: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.3 Spain: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.5.4 Spain: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.5.5 Spain: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.6 Rest of Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  • 10.3 Asia Pacific: Clinical Trial Imaging Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.3.3 Asia Pacific: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    • 10.3.4 Asia Pacific: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    • 10.3.5 Asia Pacific: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
    • 10.3.6 Asia Pacific: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
      • 10.3.6.1 China: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.1 China: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.2 China: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.1.3 China: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.1.4 China: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.2 Japan: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.1 Japan: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.2 Japan: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.2.3 Japan: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.2.4 Japan: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.3 India: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.1 India: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.2 India: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.3.3 India: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.3.4 India: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.4 South Korea: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.1 South Korea: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.2 South Korea: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.4.3 South Korea: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.4.4 South Korea: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.5 Australia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.1 Australia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.2 Australia: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.5.3 Australia: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.5.4 Australia: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.1 Rest of Asia Pacific: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.2 Rest of Asia Pacific: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  • 10.4 South and Central America: Clinical Trial Imaging Market
    • 10.4.1 Overview
    • 10.4.2 South and Central America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.3 South and Central America: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    • 10.4.4 South and Central America: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    • 10.4.5 South and Central America: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.4.5.1 Brazil: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.1.1 Brazil: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.1.2 Brazil: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.4.5.1.3 Brazil: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.4.5.1.4 Brazil: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.4.5.2 Argentina: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.2.1 Argentina: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.2.2 Argentina: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.4.5.2.3 Argentina: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.4.5.2.4 Argentina: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.4.5.3 Rest of South and Central America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.3.1 Rest of South and Central America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.3.2 Rest of South and Central America: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.4.5.3.3 Rest of South and Central America: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.4.5.3.4 Rest of South and Central America: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  • 10.5 Middle East & Africa Clinical Trial Imaging Market
    • 10.5.1 Overview
    • 10.5.2 Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.5.3 Middle East & Africa: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    • 10.5.4 Middle East & Africa: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    • 10.5.5 Middle East & Africa Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
    • 10.5.6 Middle East & Africa: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
      • 10.5.6.1 South Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.1 Overview
        • 10.5.6.1.2 South Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.3 South Africa: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.5.6.1.4 South Africa: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.5.6.1.5 South Africa Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.5.6.2 Saudi Arabia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.1 Overview
        • 10.5.6.2.2 Saudi Arabia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.3 Saudi Arabia: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.5.6.2.4 Saudi Arabia: Clinical Trial Imaging Market, by Product and Services, 2020-2028 (US$ Million)
        • 10.5.6.2.5 Saudi Arabia Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.5.6.3 UAE: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.1 Overview
        • 10.5.6.3.2 UAE: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.3 UAE: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.5.6.3.4 UAE: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.5.6.3.5 UAE Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.5.6.4 Rest of Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.4.1 Overview
        • 10.5.6.4.2 Rest of Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.4.3 Rest of Middle East & Africa: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.5.6.4.4 Rest of Middle East & Africa: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.5.6.4.5 Rest of Middle East & Africa Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Clinical Trial Imaging Market

  • 11.1 North America: Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 South and Central America: Impact Assessment of COVID-19 Pandemic
  • 11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12. Clinical Trial Imaging Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Clinical Trial Imaging Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 eResearch Technology Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Calyx Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 ICON PLC
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 VIDA Diagnostics Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 WCG Clinical Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 BioTelemetry Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Medical Metrics Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Medpace Holdings Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Radiant Sage LLC
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 IXICO plc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. US Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Canada: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Mexico: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Mexico: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Mexico: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Europe Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Europe Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Europe Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Germany: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Germany: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Germany: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. UK Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. UK Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. UK Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. France: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. France: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. France: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Italy: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Italy: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Italy: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Spain: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Spain: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Spain: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Rest of Europe: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Rest of Europe: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Rest of Europe: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Asia Pacific Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Asia Pacific Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Asia Pacific Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 37. China Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 38. China Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 39. China Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Japan Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Japan Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Japan Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 43. India Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 44. India Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 45. India Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 46. South Korea Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 47. South Korea Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 48. South Korea Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Australia Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Australia Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 51. Australia Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Rest of Asia Pacific Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Rest of Asia Pacific Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Rest of Asia Pacific Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 55. South and Central America Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 56. South and Central America Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 57. South and Central America Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 58. Brazil Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 59. Brazil Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 60. Brazil Clinical Trial Imaging Market, by End Use- Revenue and Forecast to 2028 (US$ Million)
  • Table 61. Argentina Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 62. Argentina Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 63. Argentina Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 64. Rest of South and Central America Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 65. Rest of South and Central America Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 66. Rest of South and Central America Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 67. Middle East & Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Middle East & Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Middle East & Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. South Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 71. South Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. South Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Saudi Arabia Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Saudi Arabia Clinical Trial Imaging Market, by Product and Services - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Saudi Arabia Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 76. UAE Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. UAE Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 78. UAE Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 79. Rest of Middle East & Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. Rest of Middle East & Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 81. Rest of Middle East & Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Recent Inorganic Growth Strategies in the Clinical Trial Imaging Market
  • Table 83. Recent Organic Growth Strategies in Clinical Trial Imaging Market
  • Table 84. Glossary of Terms

List Of Figures

  • Figure 1. Clinical Trial Imaging Market Segmentation
  • Figure 2. Clinical Trial Imaging Market by Region
  • Figure 3. Global Clinical Trial Imaging Market Overview
  • Figure 4. Tomography Largest Share of Modality Segment in Clinical Trial Imaging Market
  • Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Clinical Trial Imaging Market, by Geography (US$ Million)
  • Figure 7. Global Clinical Trial Imaging Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Clinical Trial Imaging Market - Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East and Africa: PEST Analysis
  • Figure 13. South and Central America: PEST Analysis
  • Figure 14. Clinical Trial Imaging Market: Impact Analysis of Drivers and Restraints
  • Figure 15. Global Clinical Trial Imaging Market - Revenue Forecast and Analysis - 2021-2028
  • Figure 16. Global Clinical Trial Imaging Market, by Geography - Forecast and Analysis (2022-2028)
  • Figure 17. Market Positioning of Key Players in the Clinical Trial Imaging Market
  • Figure 18. Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
  • Figure 19. Tomography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Ultrasound: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. PET: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. X-Ray: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Echocardiography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Magnetic Resonance Imaging: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
  • Figure 27. Trial Design Consulting Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Read Analysis Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Operational Imaging Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Imaging Software: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Clinical Trial Imaging Market Revenue Share, by End User (2022 and 2028)
  • Figure 33. Pharmaceutical and Biopharmaceutical Companies: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Contract Research Organizations: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Academic and Research Institutes: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. North America: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 38. North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. North America: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
  • Figure 40. US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. Europe: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 44. Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Europe: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
  • Figure 46. Germany: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. UK: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. France: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Italy: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. Spain: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. Rest of Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. Asia Pacific: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 53. Asia Pacific Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. China Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 55. Japan Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. India Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 57. South Korea Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. Australia Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. Rest of Asia Pacific Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. South and Central America: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 61. South and Central America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Brazil Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. Argentina Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. Rest of South and Central America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 65. Middle East & Africa: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 66. Middle East & Africa Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. South Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. Saudi Arabia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. UAE: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. Rest of Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 71. Impact of COVID-19 Pandemic on North American Country Markets
  • Figure 72. Impact of COVID-19 Pandemic on European Country Markets
  • Figure 73. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
  • Figure 74. Impact of COVID-19 Pandemic on South and Central America Country Markets
  • Figure 75. Impact of COVID-19 Pandemic on Middle East and Africa Country Markets
  • Figure 76. Growth Strategies in Clinical Trial Imaging Market